Small Molecule Exponential Discovery

X‑Chem offers a data‑rich, technology‑driven approach to small‑molecule drug discovery, helping organizations accelerate progress from hit identification to clinical‑ready candidates. Their discovery model blends DNA‑encoded library screening with advanced computational sciences and medicinal chemistry, enabling confident hit validation, clear SAR insights, and informed lead prioritization for even the most challenging targets. With decades of experience across diverse therapeutic areas, X‑Chem supports partners with optimized DMPK profiling, scalable chemistry, and streamlined workflows that reduce handoffs and de‑risk decision‑making. Teams gain access to hundreds of billions of high‑quality small molecules, tailored or off‑the‑shelf DEL solutions, and optional training to strengthen internal capabilities. This integrated framework empowers drug hunters to progress faster, innovate more effectively, and unlock new opportunities for impactful therapeutic design.

Explore the full brochure to see how X‑Chem strengthens early‑stage discovery programs.